Yolia’s True Vision Treatment (TVT) is a safe, non-invasive and repeatable procedure for treating presbyopia. TVT is self-administered by the patient in his or her own home. It employs a combination of personalized gas-permeable contact lenses and specially formulated eye drops – which, when used together, safely modifies the sphericity of the patient’s cornea leading to superior vision. After only 5 days of treatment with TVT patients are able to stop using the personalized contact lenses, specially formulated eye drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia’s treatment improves both near and distance vision, a unique feature no single other alternative can provide.
Yolia is looking for $500K in funds that will be used to complete the commercial test in Mexico. The next stage of development will be to launch TVT by 2014 and pursue other less regulated markets (LATAM) before European and United States Food and Drug Administration (FDA) clinical trials. A second round of financing is forecasted for the first quarter of 2014 for approximate $5 million.